As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.
7 Analysts have issued a MedCap AB forecast:
7 Analysts have issued a MedCap AB forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 1,991 1,991 |
11%
11%
|
|
| Gross Profit | 1,156 1,156 |
39%
39%
|
|
| EBITDA | 403 403 |
1%
1%
|
|
| EBIT (Operating Income) EBIT | 271 271 |
8%
8%
|
|
| Net Profit | 197 197 |
14%
14%
|
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Stockholm, Stockholm and currently employs 583 full-time employees. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
| Head office | Sweden |
| Employees | 592 |
| Website | www.medcap.se |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


